Haematology Books

Book SynopsisTrade ReviewAccolades for Previous Editions: Best Book in Medical Science Award --Association of American Publishers Highly Commended Prize (Internal Medicine) --British Medical Association Medical Book Awards "Belongs on the bookshelf of every clinician who assesses patients with platelet disorders" --The Lancet "Landmark" --New England Journal of Medicine "This is a fantastic resource for anyone who treats patients with platelet disorders or is engaged in platelet or megakaryocyte-based research" --British Journal of HaematologyTable of ContentsPART I: Platelet Biology 1. The Evolution of Mammalian Platelets 2. Megakaryocyte Development and Platelet Formation 3. The Structure of Resting and Activated Platelets 4. Platelet Glycobiology and the Control of Platelet Function and Lifespan 5. Platelet Genomics 6. Platelet MicroRNAs 7. The Platelet Transcriptome in Health and Disease 8. The Platelet Proteome 9. Platelet Receptors 10. The Glycoprotein Ib-IX-V Complex 11. GPVI and CLEC-2 12. Integrin aIIbß3 13. Protease-Activated Receptors 14. The Platelet P2 Receptors 15. Platelet Inhibitory Receptors 16. Interactions Between Platelets, Leukocytes, and the Endothelium 17. Inhibition of Platelet Function by the Endothelium 18. Platelet Signal Transduction 19. Platelet Secretion 20. Hemostatic Thrombus Formation in Flowing Blood 21. Interactions Between Platelets and the Coagulation System 22. Platelet-Derived Extracellular Vesicles 23. Regulation of Fibrinolysis by Platelets 24. The Role of Platelets in Angiogenesis 25. Platelet Function in the Newborn PART II: The Role of Platelets in Disease 26. The Role of Platelets in Atherothrombosis 27. The Role of Platelets in Diabetes Mellitus 28. The Role of Platelets in Inflammation 29. The Role of Platelets in Antimicrobial Host Defense 30. The Role of Platelets in Tumor Growth, Metastasis, and Immune Evasion 31. The Role of Platelets in Sickle Cell Disease PART III: Clinical Tests of Platelet Function 32. Platelet Counting 33. Clinical Tests of Platelet Function 34. Platelet Aggregation 35. Flow Cytometry 36. Laboratory Monitoring of Antiplatelet Therapy 37. Platelet Function Testing in Clinical Research Trials PART IV: Disorders of Platelet Number and/or Function 38. The Clinical Approach to Disorders of Platelet Number and Function 39. Immune Thrombocytopenia (ITP) 40. Drug-Induced Thrombocytopenia 41. Heparin-Induced Thrombocytopenia 42. Thrombotic Thrombocytopenic Purpura and Hemolytic-Uremic Syndromes 43. Thrombocytopenia in Pregnancy 44. Thrombocytopenia in the Newborn 45. Alloimmune Thrombocytopenia 46. Inherited Thrombocytopenias 47. Thrombocytosis and Essential Thrombocythemia 48. Inherited Disorders of Platelet Function 49. Acquired Disorders of Platelet Function PART V: Antiplatelet Therapy 50. Aspirin 51. P2Y12 Antagonists 52. aIIbß3 (GPIIb-IIIa) Antagonists 53. PAR-1 Antagonists 54. Phosphodiesterase Inhibitors 55. Novel Antiplatelet Therapies 56. Antiplatelet Drugs in the Management of Coronary Artery Disease 57. Antiplatelet Drugs in the Management of Cerebral Ischemia 58. Antiplatelet Drugs in the Management of Thrombotic/Ischemic Events in Peripheral Artery Disease 59. Antiplatelet Drugs in the Management of Venous Thromboembolism, Cardioembolism, Ventricular Assist Devices, and Pregnancy Complications 60. Antiplatelet Drugs in the Management of Thrombotic/Ischemic Events in Children PART VI: Therapy to Increase Platelet Numbers and/or Function 61. Thrombopoietin Receptor Agonists 62. Desmopressin (DDAVP) 63. Factor VIIa 64. Platelet Transfusion Medicine 65. Therapeutic Platelet-Rich Plasma in Wound Healing 66. Stem Cell-Derived Platelets 67. Gene Therapy for Platelet Disorders

Read more less

Book SynopsisTable of ContentsIsaacs: Hoffman and Abeloff's Hematology-Oncology Review 1. Cancer biology and Genomics 2. Tumor Immunology 3. Anti-Cancer Therapies SECTION 1: Chemotherapy SECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors 4. Clinical Trial Design and Ethics 5. Hereditary Cancer Syndromes HEMATOLOGIC MALIGNANCIES 6. Acute Myeloid Leukemia and Myelodysplastic Syndrome 7. Myeloproliferative Disorders 8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders 9: Hodgkin lymphoma 10. Non-Hodgkin Lymphoma 11. Multiple myeloma and other plasma cell dyscrasias 12. T cell and NK cell neoplasms and other lymphoid malignancies 13. Hematopoeietic Cell Transplantation SOLID TUMOR MALIGNANCIES 14. Breast cancer a: Early Stage Breast Cancer b: Metastatic breast cancer e. Premalignant breast conditions and in situ disease 15. Lung Cancer a: Non-small cell lung cancer b: Small cell lung cancer 16. Other Thoracic Malignancies a: Mesothelioma b: Thymoma and thymic cancer 17. Head and Neck cancer 18 : Esophageal Cancer 19: Gastric cancer 20: Pancreatic cancer 21: Colorectal cancer and Anal Cancer 22: Hepatobiliary cancer 23: Neuroendocrine, small bowel and appendiceal malignancies 24. Prostate cancer 25. Bladder and other urothelial cancers 26. Renal Carcinomas 27. Germ cell tumors 28. Gynecological Malignancies Ovarian Cancer and Fallopian Tube Cancer Cancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma 29. Melanoma and other skin cancers 30. Bone and soft tissue sarcoma 31.Cancer of unknown primary site 32. . Malignancies of the Central Nervous System a. Primary b. Metastatic NONMALIGNANT HEMATOLOGIC CONDITIONS 33. Coagulation 34. Hematopoietic System 1: Hematopoietic System Disorders RBC or iron 35. Transfusion Medicine SURVIVORSHIP AND END OF LIFE CARE Chapter 36. Supportive Care

Read more less

Book SynopsisTrade Review"This comprehensive book is well conceived, well organized, and well presented. This impressive and authoritative work embodies a formal textbook on hemostasis and thrombosis." -Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 100-5 Stars!Table of ContentsKitchens: CONSULTATIVE HEMOSTASIS & THROMBOSIS TOC PART 1: Hemorrhagic Processes 1. Consultative Process 2. An Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing 3. Hemophilia A and B 4. Less Common Congenital Disorders of Hemostasis 5. Acquired Coagulation Disorders Due to Inhibitors 6. von Willebrand Disease 7. General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors 8. Primary Immune Thrombocytopenia 9. Congenital and Acquired Disorders of Platelet Function and Number 10. Purpura and Other Hematovascular Disorders 11. HHT 12. Disseminated Intravascular Coagulation 13. The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation PART 2: Thrombotic Processes 14. Thrombophilia: Clinical and Laboratory Assessment and Management 15. Pediatric Aspects of Thrombophilia 16. Deep Vein Thrombosis, Pulmonary Embolism and Primary Pulmonary Hypertension 17. Venous Thromboses at Unusual Sites 18. The Post Thrombotic Syndrome 19. Thrombocytosis: Essential Thrombocytemia and Reactive Causes 20. Antiphospholipid Syndrome 21. Antiplatelet Treatment in Cardiovascular Medicine 22. Non-Arteriosclerotic Arterial Occlusive Disease 23. Thrombosis and Cancer 24. Thrombotic Thrombocytopenic Purpura 25. Hemostatic Disorders of Complement Activation (PNH and aHUS) - New Chapter 26. Heparin-Induced Thrombocytopenia PART 3: Therapeutic Agents 27. Antithrombotic Agents 28. Blood Component and Pharmacological Agents 29. Therapeutic Apheresis â?" Applications for Hemorrhagic & Thrombotic Disorders 30. Vena Caval Filters PART 4: Issues Specific to Women 31. Thrombotic Risk of Contraceptives and other Hormnal Therapies 32. Bleeding and the Management of Hemorrhagic Disorders in Pregnancy 33. Thrombophilia in Pregnancy PART 5: Special Issues 34. Surgery and Hemostasis 35. Anticoagulation in the Perioperative Period 36. Understanding and Managing the Coagulopathy of Liver Disease 37. Outpatient Anticoagulant Therapy38. Hematologic Interventions for Acute Central Nervous System Disease 39. Pending: Atrial Septal Abnormalties and Cryptogenic Stroke 40. Hemorrhage Control and Thrombosis Following Severe Injury 41. Hemostatic Aspects of Sickle Cell Disease

Read more less

Book SynopsisTrade Review"This is a great addition to the current offerings of clinical hematology or hematopathology atlases, filling a specialized and practical niche where these clinical services intersect in real life (e.g., tumor boards).” - ©Doody's Review Service, 2021, Valerie L. Ng, PhD, MD (Alameda County Medical Center/Highland Hospital) Doody's Score: 90 - 4 Stars!Table of ContentsNormal Hemopoiesis and Blood Cell Maturation Growth Factors Hypochromic and Hemolytic Anemias Megaloblastic Anemia Myeloproliferative Neoplasms Mast Cell and Non-Myeloproliferative Myeloid Neoplasms Myelodysplastic Syndromes Acute Myeloid Leukemia Precursor Lymphoid Neoplasms B-Cell Chronic Lymphoid Leukemias Hodgkin Lymphoma Indolent and Aggressive B-Cell Lymphoma Indolent and Aggressive Mature T-Cell and Natural Killer-Cell Lymphomas Myeloma and Related Conditions Childhood Hematopoietic Disorders Posttransplant Lymphoproliferative Disorders and Immunodeficiency Infectious Processes in Blood and Bone Marrow Hemophilia Transfusion Medicine and Cellular Therapy

Read more less

Book SynopsisTable of ContentsPart 1. Cytotoxic Chemotherapy 1. Mechanism of Chemotherapy in Cancer Treatment 2. Neutropenic Complications of Chemotherapy 3. Chemotherapy Induced Anemia 4. Cancer Treatment Related Thrombocytopenia 5. Oral Mucositis 6. Gastrointestinal Complications of Chemotherapy 7. Neurological Complications 8. Pulmonary Toxicities of Cytotoxic Chemotherapy 9. Dermatological Complications of Chemotherapy 10. Cardiotoxicities of Chemotherapy 11. Management of Cancer Treatment Infusion Reactions Part 2. Targeted Therapies 12. Mechanism of Targeted Therapies in Cancer Treatment 13. Gastrointestinal Complications 14. Pulmonary Toxicities of Molecular Targeted Therapies 15. Dermatologic Toxicities 16. Cardiotoxicities Part 3. Immunotherapies 17. Mechanism of Immune-Related Adverse Events 18. Endocrine Toxicities 19. Gastrointestinal Toxicities 20. Neurological Complications of Immunotherapy 21. Pulmonary Toxicities 22. Dermatological Complications 23. Immunotherapy-Induced Cardiotoxicities 24. Rheumatological Complications Part 4. Radiation Therapy 25. Mechanisms of Radiation-Related Toxicities 26. Radiation-Induced Mucositis and Esophagitis 27. Radiation Therapy Related Dermatologic Toxicities 28. Pulmonary Toxicity from Radiation Therapy 29. Radiation-Induced Cardiotoxicities

Read more less

Book SynopsisTrade Review"The breadth and meticulous detail of this book are a testament to its editors, all of whom are internationally regarded experts in hematology." © The ASCO Post 2023, Ronald PianaTable of ContentsPART I MOLECULAR AND CELLULAR BASIS OF HEMATOLOGY 1. Anatomy and Physiology of the Gene 2. Epigenomics in Hematology 3. Genomic Approaches to Hematology 4. Regulation of Gene Expression in Hematology 5. Genome Editing 6. Signaling Transduction and Metabolomics 7. Protein Architecture: Relationship of Form and Function 8. Pharmacogenomics and Hematologic Diseases PART II CELLULAR BASIS OF HEMATOLOGY 9. Hematopoietic Stem Cell Biology 10. Mitochondria and Hematopoiesis 11. Cytokines, Chemokines, Other Growth Factors, and Their Receptors 12. Role of Chemokines in Leukocyte Trafficking 13. Stem Cell Model of Hematologic Diseases 14. Hematopoietic Microenvironment 15. Cell Adhesion 16. Current Biology of Stem Cell Homing and Mobilization: Dynamic Interactions Between Hematopoietic Stem and Progenitor Cells and Their Surrounding Bone Marrow Microenvironment 17. Control of Cell Division 18. Cell Death 19. Aging and Hematopoiesis PART III IMMUNOLOGIC BASIS OF HEMATOLOGY 20. Dendritic Cell Biology 21. Natural Killer Cell Immunity and Therapy 22. B-Cell Development 23. Complement and Immunoglobulin Biology Leading to Clinical Translation 24. T-Cell Immunity 25. Unmodified Ex Vivo Expanded T Cells 26. Treatment of Hematologic Malignancies with Genetically Modified T Cells PART IV DISORDERS OF HEMATOPOIETIC CELL DEVELOPMENT 27. Biology of Erythropoiesis, Erythroid Differentiation, and Maturation 28. Granulocytopoiesis and Monocytopoiesis 29. Thrombocytopoiesis 30. Inherited Bone Marrow Failure Syndromes 31. Aplastic Anemia 32. Paroxysmal Nocturnal Hemoglobinuria 33. Acquired Disorders of Red Cell, White Cell, and Platelet Production PART V RED BLOOD CELLS 34. Pathobiology of the Human Erythrocyte and Its Hemoglobins 35. Approach to Anemia in the Adult and Child 36. Iron Homeostasis and Its Disorders 37. Disorders of Iron Homeostasis: Iron Deficiency and Overload 38. Anemia of Chronic Inflammation 39. Heme Biosynthesis and Its Disorders: Porphyrias and Sideroblastic Anemias 40. Megaloblastic Anemias 41. Thalassemia Syndromes 42. Pathobiology of Sickle Cell Disease 43. Clinical Aspects of Sickle Cell Disease 44. Hemoglobin Variants Associated with Hemolytic Anemia, Altered Oxygen Affinity, and Methemoglobinemias 45. Red Blood Cell Enzymopathies 46. Red Blood Cell Membrane Disorders 47. Autoimmune Hemolytic Anemia 48. Extrinsic Nonimmune Hemolytic Anemias PART VI NON-MALIGNANT LEUKOCYTES 49. Neutrophilic Leukocytosis, Neutropenia, Monocytosis, and Monocytopenia 50. Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia 51. Disorders of Phagocyte Function 52. Congenital Disorders of Lymphocyte Function 53. Pediatric and Adult Histiocytic Disorders 54. Lysosomal Storage Diseases, Focusing on Gaucher Disease: Perspectives and Principles 55. Epstein-Barr Virus and Associated Lymphoproliferative Conditions PART VII HEMATOLOGIC MALIGNANCIES 56. Progress in the Classification of Hematopoietic and Lymphoid Neoplasms: Clinical Implications 57. Conventional and Molecular Cytogenomic Basis of Hematologic Malignancies 58. Pharmacology and Molecular Mechanisms of Antineoplastic Agents for Hematologic Malignancies 59. Pathobiology of Acute Myeloid Leukemia 60. Clinical Manifestations and Treatment of Acute Myeloid Leukemia 61. Myelodysplastic Syndromes 62. Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome in Adults 63. Acute Myeloid Leukemia in Children 64. Blastic Plasmacytoid Dendritic Cell Neoplasm 65. Myelodysplastic Syndromes and Myeloproliferative Neoplasms in Children 66. Pathobiology of Acute Lymphoblastic Leukemia 67. Clinical Manifestations and Treatment of Childhood Acute Lymphoblastic Leukemia 68. Acute Lymphoblastic Leukemia in Adults 69. Chronic Myeloid Leukemia 70. The Polycythemias 71. Essential Thrombocythemia 72. Primary Myelofibrosis and Chronic Neutrophilic Leukemia 73. Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes 74. Eosinophilia, Eosinophilic Neoplasms, and the Hypereosinophilic Syndromes 75. Mast Cells and Mastocytosis 76. Chronic Lymphocytic Leukemia 77. Hairy Cell Leukemia 78. The Pathologic Basis for the Classification of Non-Hodgkin and Hodgkin Lymphomas 79. Origin of Hodgkin Lymphoma and Therapeutic Targets 80. Hodgkin Lymphoma 81. Origin of Non-Hodgkin Lymphoma and Therapeutic Targets 82. Clinical Manifestations, Staging, and Treatment of Follicular Lymphoma 83. Marginal Zone Lymphomas (Extranodal/MALT, Splenic, and Nodal) 84. Diffuse Large B-Cell Lymphoma of the Central Nervous System 85. High-Grade B-Cell Lymphomas 86. Mantle Cell Lymphoma 87. Virus-Associated Lymphoma 88. Malignant Lymphomas in Childhood 89. T-Cell Lymphomas 90. Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma 91. Multiple Myeloma 92. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma 93. Immunoglobulin Light-Chain Amyloidosis (Primary Amyloidosis) PART VIII COMPREHENSIVE CARE OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES 94. Key Considerations for Managing Infections in the Compromised Host 95. Principles of Radiation Therapy for Hematologic Disease 96. Grading and Toxicity Management after Immune Effector Therapy 97. Identification and Management of Checkpoint Inhibition Toxicity 98. Psychosocial Aspects of Hematologic Disorders 99. Pain Management and Antiemetic Therapy in Hematologic Disorders 100. Palliative Care 101. Therapy-related Late Effects of Hematologic Malignancies PART IX TRANSPLANTATION AND OTHER CELL-BASED THERAPIES 102. Practical Aspects of Hematopoietic Stem Cell Harvesting and Mobilization 103. Graft Engineering and Cell Processing 104. Principles of Cell-Based Genetic Therapies 105. Indications, Outcomes, and Donor Selection for Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies in Adults 106. Unrelated Donor Hematopoietic Cell Transplantation 107. Haploidentical Hematopoietic Stem Cell Transplantation 108. Cord Blood Transplantation 109. Graft-versus-Host Disease and Graft-versus- Leukemia Responses 110. Supportive Care for the Transplant Patient PART X TRANSFUSION MEDICINE 111. Human Blood Group Antigens and Antibodies 112. Principles of Red Blood Cell Transfusion 113. Clinical Considerations in Platelet Transfusion Therapy 114. Human Leukocyte Antigen and Human Neutrophil Antigen Systems 115. Principles of Plasma and Plasma Derivatives 116. Hemapheresis 117. Transfusion Reactions to Blood and Hematopoietic Stem Cell Therapy Products 118. Transfusion-Transmitted Diseases 119. Pediatric Transfusion Medicine 120. Transfusion and Apheresis Support for Sickle Cell Disease Patients PART XI HEMOSTASIS AND THROMBOSIS 121. Overview of Hemostasis and Thrombosis 122. Blood Vessels 123. Megakaryocyte and Platelet Structure 124. Molecular Basis of Platelet Function 125. Molecular Basis of Blood Coagulation 126. Evaluation of the Patient with Suspected Bleeding Disorders 127. Laboratory Evaluation of Hemostatic and Thrombotic Disorders 128. Acquired Disorders of Platelet Function 129. Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal Alloimmune Thrombocytopenia, and Posttransfusion Purpura 130. Thrombocytopenia Caused by Hypersplenism, Platelet Destruction, or Surgery/Hemodilution 131. Heparin-Induced Thrombocytopenia 132. Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndromes 133. Structure, Biology, and Genetics of von Willebrand Factor 134. Hemophilia A and B 135. Rare Coagulation Factor Deficiencies 136. Transfusion Therapy for Coagulation Factor Deficiencies 137. Disseminated Intravascular Coagulation 138. Hypercoagulable States 139. Antiphospholipid Syndrome 140. Venous Thromboembolism 141. Prevention and Treatment of Venous Thromboembolism in Pregnancy 142. Atherothrombosis 143. Antithrombotic Drugs 144. Stroke 145. Acute Coronary Syndromes 146. Peripheral Artery Disease 147. Atrial Fibrillation 148. Bleeding and Clotting Disorders in Pediatrics PART XII CONSULTATIVE HEMATOLOGY 149. Hematologic Changes in Pregnancy 150. Hematologic Manifestations of End-Organ Failure 151. Hematologic Manifestations of Solid Tumors 152. Hematologic Manifestations of HIV/AIDS 153. Hematologic Findings and Consequences of Novel Coronavirus (SARS-CoV-2) Infection 154. Hematologic Aspects of Parasitic Diseases 155. Hematologic Problems in the Surgical Patient: Bleeding and Thrombosis 156. The Spleen and Its Disorders 157. Aging and Hematologic Disorders 158. Onco-cardiology: Focus on Cardiac Complications of Hematologic Treatments 159. Resources for the Hematologist: Interpretive Comments and Selected Reference Values for Neonatal, Pediatric, and Adult Populations 2408.e1 Chapter 159 can be found online at Elsevier eBooks for Practicing Clinicians Index

Read more less

Book SynopsisTrade Review"This book has grown since the first edition to maintain its standing as a comprehensive text (including 14 new chapters). Overall, this book provides all the essential knowledge on splenic pathology in one single resource. It is ideal for daily use as a reference but is also an excellent training resource for learners." ©Doody's Review Service, 2022, Anna B Owczarczyk, MD, PHD (University of Michigan Medical School) Doody's Score: 5 Stars!Table of ContentsSECTION 1: HISTOLOGY, FUNCTION, AND DEVELOPMENT OF SPLEEN NORMAL HISTOLOGY 4 Introduction to Spleen Mohammad A. Vasef, MD and Jeremy C. Wallentine, MD 12 Imaging of Splenic Disorders Mohammad A. Vasef, MD 18 Handling, Processing, and Gross Pathology of Spleen Mohammad A. Vasef, MD 26 Fine-Needle Aspiration and Core Biopsy of Spleen Mohammad A. Vasef, MD 32 Immunohistochemistry of Spleen Aaron Auerbach, MD, MPH 40 Flow Cytometry Nadine Aguilera, MD 46 Molecular Techniques Nadine Aguilera, MD SECTION 2: NONNEOPLASTIC SPLENIC DISORDERS LYMPHOID HYPERPLASIA 54 Florid Follicular Hyperplasia Jeremy C. Wallentine, MD and Aaron Auerbach, MD, MPH 56 Autoimmune Disease Nadine Aguilera, MD 62 HIV in Spleen Nadine Aguilera, MD 68 Castleman Disease Nadine Aguilera, MD 70 Marginal Zone Hyperplasia Jeremy C. Wallentine, MD and Aaron Auerbach, MD, MPH GRANULOMATOUS LESIONS/DISORDERS 72 Lipogranulomas Jeffrey Vos, MD 78 Sarcoidosis Ellina Hall, DO and Aaron Auerbach, MD, MPH 82 Chronic Granulomatous Disease Aaron Auerbach, MD, MPH INFECTIONS 86 Mycobacteriosis Nadine Aguilera, MD 90 Selected Bacterial Infections Aaron Auerbach, MD, MPH 94 Candidiasis Aaron Auerbach, MD, MPH 96 Histoplasmosis Nadine Aguilera, MD 98 Cryptococcosis Nadine Aguilera, MD 100 Coccidioidomycosis Aaron Auerbach, MD, MPH 104 Pneumocystosis Aaron Auerbach, MD, MPH 108 Infectious Mononucleosis Nadine Aguilera, MD 112 Cytomegalovirus Infection Nadine Aguilera, MD 114 Herpes Simplex Virus Infection Aaron Auerbach, MD, MPH and Nadine Aguilera, MD 116 Echinococcosis Aaron Auerbach, MD, MPH 120 Malaria Nadine Aguilera, MD NONINFECTIOUS CYSTS 122 Epithelial Cyst Ellina Hall, DO and Aaron Auerbach, MD, MPH 124 False Cyst Ellina Hall, DO and Aaron Auerbach, MD, MPH NONNEOPLASTIC VASCULAR PROCESSES 126 Chronic Passive Congestion Ellina Hall, DO and Aaron Auerbach, MD, MPH 128 Infarct Jeffrey Vos, MD 136 Peliosis Ellina Hall, DO and Aaron Auerbach, MD, MPH 138 Sclerosing Angiomatoid Nodular Transformation Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD RED CELL DISORDERS 144 Sickle Cell Disease Aaron Auerbach, MD, MPH and Ellina Hall, DO 146 Thalassemia Nadine Aguilera, MD and Aaron Auerbach, MD, MPH 150 Hereditary Spherocytosis Nadine Aguilera, MD 152 Thrombotic Thrombocytopenic Purpura Aaron Auerbach, MD, MPH MISCELLANEOUS LESIONS/DISORDERS 158 Heterotaxy Syndromes Aaron Auerbach, MD, MPH 160 Congenital Splenic Abnormalities Nadine Aguilera, MD 164 Extramedullary Hematopoiesis Ellina Hall, DO and Aaron Auerbach, MD, MPH 166 Gamna-Gandy Bodies Nadine Aguilera, MD 168 Hemophagocytic Lymphohistiocytosis Nadine Aguilera, MD 174 Immune Thrombocytopenic Purpura Ellina Hall, DO and Aaron Auerbach, MD, MPH 178 Niemann-Pick Disease Meenakshi A. Nandedkar, MD and Nadine Aguilera, MD 184 Gaucher Disease Meenakshi A. Nandedkar, MD and Nadine Aguilera, MD 188 Sea-Blue (Ceroid) Histiocytosis Mohammad A. Vasef, MD 192 Gangliosidosis Lysosomal Disorder Mohammad A. Vasef, MD 194 Therapy Effect on Spleen Aaron Auerbach, MD, MPH 202 Traumatic and Nontraumatic Splenic Injuries Mohammad A. Vasef, MD SECTION 3: NEOPLASTIC SPLENIC DISORDERS BENIGN MESENCHYMAL LESIONS 208 Introduction to Vascular Lesions Nadine Aguilera, MD 210 Hemangioma Nadine Aguilera, MD 218 Lymphangioma Nadine Aguilera, MD 222 Littoral Cell Angioma Nadine Aguilera, MD 228 Inflammatory Pseudotumor Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 236 Postchemotherapy Histiocyte-Rich Pseudotumor of Spleen Roberto N. Miranda, MD and L. Jeffrey Medeiros, MD 242 Splenic Hamartoma Nadine Aguilera, MD 246 Myelolipoma Aaron Auerbach, MD, MPH MALIGNANT OR POTENTIALLY MALIGNANT MESENCHYMAL LESIONS 248 Angiosarcoma Nadine Aguilera, MD 256 Hemangioendothelioma Nadine Aguilera, MD 258 Kaposi Sarcoma Nadine Aguilera, MD 260 Leiomyosarcoma Aaron Auerbach, MD, MPH 266 Gastrointestinal Stromal Tumor Aaron Auerbach, MD, MPH 272 Follicular Dendritic Cell Sarcoma Aaron Auerbach, MD, MPH 280 Inflammatory Pseudotumor-Like Follicular Dendritic Cell Sarcoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 286 Langerhans Cell Histiocytosis Guanghua Wang, MD 292 Histiocytic Sarcoma Nadine Aguilera, MD LYMPHOMA 300 Introduction to Lymphoma Mohammad A. Vasef, MD 310 Splenic Marginal Zone Lymphoma Roberto N. Miranda, MD and L. Jeffrey Medeiros, MD 318 Hairy Cell Leukemia Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 326 Hairy Cell Leukemia Variant Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 334 Lymphoplasmacytic Lymphoma Aaron Auerbach, MD, MPH 342 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 350 Follicular Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 358 Mantle Cell Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 366 Leukemic Nonnodal Mantle Cell Lymphoma Mohammad A. Vasef, MD 370 Splenic Diffuse Red Pulp B-Cell Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 376 B-Cell Prolymphocytic Leukemia Aaron Auerbach, MD, MPH and Nadine Aguilera, MD 378 Diffuse Large B-Cell Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 384 Fibrin-Associated Large B-Cell Lymphoma in Splenic False Cyst Mohammad A. Vasef, MD 390 T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Jeffrey Vos, MD 398 Burkitt Lymphoma Aaron Auerbach, MD, MPH 406 Classic Hodgkin Lymphoma Jeffrey Vos, MD 416 Nodular Lymphocyte-Predominant Hodgkin Lymphoma Aaron Auerbach, MD, MPH 426 Peripheral T-Cell Lymphoma, Unspecified Mohammad A. Vasef, MD 432 Hepatosplenic T-Cell Lymphoma Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 440 T-Cell Prolymphocytic Leukemia Mohammad A. Vasef, MD 448 T-Cell Large Granular Lymphocytic Leukemia Roberto N. Miranda, MD, Mario L. Marques-Piubelli, MD, and L. Jeffrey Medeiros, MD 456 Aggressive NK-Cell Leukemia Aaron Auerbach, MD, MPH 462 Transformation of Splenic Disorders Nadine Aguilera, MD LEUKEMIA 466 Acute Myeloid Leukemia Nadine Aguilera, MD 474 Lymphoblastic Leukemia/Lymphoma Nadine Aguilera, MD CHRONIC MYELOPROLIFERATIVE NEOPLASMS/MYELODYSPLASTIC SYNDROMES 480 Myeloproliferative Neoplasm Overview Nadine Aguilera, MD 482 Chronic Myeloid Leukemia, BCR::ABL1 Positive Nadine Aguilera, MD 488 Essential Thrombocythemia Jeremy C. Wallentine, MD and Aaron Auerbach, MD, MPH 492 Polycythemia Vera Guanghua Wang, MD 496 Primary Myelofibrosis Jeffrey Vos, MD 506 Mastocytosis Mohammad A. Vasef, MD 514 Chronic Myelomonocytic Leukemia Mohammad A. Vasef, MD PLASMA CELL-ASSOCIATED DISORDERS 520 Amyloidosis Nadine Aguilera, MD 526 Heavy Chain Disease Aaron Auerbach, MD, MPH 530 Plasma Cell Myeloma/Plasmacytoma Nadine Aguilera, MD and Aaron Auerbach, MD, MPH METASTASIS 534 Metastatic Tumors Ellina Hall, DO and Aaron Auerbach, MD, MPH

Read more less

Book SynopsisTable of ContentsSECTION 1 HEMATOLOGY 1 Innovations in Screening and Management of Neonatal Hyperbilirubinemia 2 The Pivotal Role of Macrophages in the Pathogenesis of Necrotizing Enterocolitis 3 Nucleated Red Blood Cells in Neonatal Medicine 4 Age-Appropriate Biology of Neonatal Neutrophils 5 New Erythrocyte Diagnostic Parameters in Neonatal Medicine 6 Neonatal Iron Homeostasis 7 Risk Factors for Iron Deficiency in Neonates 8 Using Targeted Genetic Panels to Find the Causes of Neonatal Hemolytic Anemia SECTION 2 TRANSFUSION MEDICINE 9 Erythropoietin and Darbepoetin Use in the NICU 10 NICU Transfusion Guidelines and Strategies to Minimize Transfusions 11 Neonatal Blood Banking and Transfusion: Current Questions and Controversies 12 Recent Advances in NICU Platelet Transfusions 13 Novel Approaches to Identify NICU Patients Who Would Benefit From Platelet Transfusions 14 Evidence-Based Guidelines for Administering Fresh Frozen Plasma in the NICU 15 Pathophysiologic Importance of Platelets in Neonatal Necrotizing Enterocolitis Index

Read more less

Book SynopsisTable of ContentsPart 1: The Practice of Phlebotomy 1. Introduction to Phlebotomy 2. Anatomy and Physiology 3. Infectious Diseases and Their Prevention 4. Medical Terminology 5. Equipment 6. Proper Procedures for Venipuncture 7. Special Collection Procedures 8. Neonatal and Geriatric Procedures and Considerations 9. Considerations and Complications of Phlebotomy 10. The Versatile Phlebotomist and Point-of-Care Testing Part 2: Professional Issues 11. Interpersonal Communication and Professionalism 12. Phlebotomy Department Management 13. Total Quality in Phlebotomy Service 14. Medical-Legal Issues and Health Law Procedures Appendix A: Answers to Chapter Review Questions Appendix B: Practice Examination for Certification Appendix C: Helpful Spanish Terms and Phrases Glossary Index

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisDas 7. Heidelberger Symposium über Hämostaseologie in der Anästhesiologie hatte als zentrales Thema die disseminierte Gerinnungsaktivierung, wie sie bei Sepsis im Rahmen der Verbrauchskoagulopathie immer noch ein wichtiges klinisches Problem ist. Die disseminierte Gerinnungsaktivierung stellt sich immer wieder mit zwei Gesichtern dar: Zum einen ist sie ein Paradepferd der wissenschaftlichen Hämostaseologie, das Modell, an dem die Gerinnung erforscht wird, zum anderen ist sie immer wieder für Enttäuschungen und Überraschungen gut, denn kaum meint man, ein Molekül und seine Wirkung verstanden zu haben, so lehrt die klinische Erfahrung, dass dies nicht so einfach ist, wie man ursprünglich dachte.Table of Contents1 Gerinnung und Infektabwehr — Ein phylogenetisches Erfolgskonzept als Ursache disseminierter intravasaler Gerinnung?.- 2 Molekulare Basis für neue therapeutische Ansätze.- 3 Scoresysteme bei Sepsis und ihre Wertigkeit für die Stratifizierung von Patienten mit Gerinnungsstörungen und Sepsis.- 4 Was kostet die hämostaseologische Therapie?.- 5 Die Bedeutung der Gerinnung für die Prognose von Patienten mit Sepsis.- 6 Protein-C-Pathway.- 7 Klinische Ergebnisse der Protein-C- und rhAPC-Substitution.- 8 Treatment with AT III Concentrate in Pre-Eclampsia.- 9 Gerinnungsaktivierung bei Reanimation — Gibt es klinische Konsequenzen?.- 10 Disseminierte Gerinnungsaktivierung.- 11 Humane Prionenerkrankungen.

Read more less

Book SynopsisGeneral Information on Cancer Staging and End-Results Reporting.- Purposes and Principles of Cancer Staging.- Cancer Survival Analysis.- Head and Neck.- Lip and Oral Cavity.- Pharynx.- Larynx.- Nasal Cavity and Paranasal Sinuses.- Major Salivary Glands.- Thyroid.- Mucosal Melanoma of the Head and Neck.- Digestive System.- Esophagus and Esophagogastric Junction.- Stomach.- Small Intestine.- Colon and Rectum.- Anus.- Gastrointestinal Stromal Tumor.- Neuroendocrine Tumors.- Liver.- Intrahepatic Bile Ducts.- Gallbladder.- Perihilar Bile Ducts.- Distal Bile Duct.- Ampulla of Vater.- Exocrine and Endocrine Pancreas.- Thorax.- Lung.- Pleural Mesothelioma.- Musculoskeletal Sites.- Bone.- Soft Tissue Sarcoma.- Skin.- Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas.- Merkel Cell Carcinoma.- Melanoma of the Skin.- Breast.- Breast.- Gynecologic Sites.- Vulva.- Vagina.- Cervix Uteri.- Corpus Uteri.- Ovary and Primary Peritoneal Carcinoma.- Fallopian Tube.- Gestational Trophoblastic Tumors.- Genitourinary Sites.- Penis.- Prostate.- Testis.- Kidney.- Renal Pelvis and Ureter.- Urinary Bladder.- Urethra.- Adrenal.- Ophthalmic Sites.- Carcinoma of the Eyelid.- Carcinoma of the Conjunctiva.- Malignant Melanoma of the Conjunctiva.- Malignant Melanoma of the Uvea.- Retinoblastoma.- Carcinoma of the Lacrimal Gland.- Sarcoma of the Orbit.- Ocular Adnexal Lymphoma.- Central Nervous System.- Brain and Spinal Cord.- Lymphoid Neoplasms.- Lymphoid Neoplasms.Trade ReviewFrom the reviews of the seventh edition:“Provide a new organ-specific classification that oncologists and other professionals who manage patients with cancer need in order to accurately classify tumours for staging. … a ‘Bible’ for oncologists, pathologists and surgeons, being also useful for all health officers, including general physicians and students, who want to remain updated in oncology. … this is a book that has to be present in all diagnostic imaging departments, as a major support to produce information adequate to the new oncology algorithms.”­­­ (Vincenzo Cuccurullo and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, 2011)Table of ContentsGeneral Information on Cancer Staging and End-Results Reporting.- Purposes and Principles of Cancer Staging.- Cancer Survival Analysis.- Head and Neck.- Lip and Oral Cavity.- Pharynx.- Larynx.- Nasal Cavity and Paranasal Sinuses.- Major Salivary Glands.- Thyroid.- Mucosal Melanoma of the Head and Neck.- Digestive System.- Esophagus and Esophagogastric Junction.- Stomach.- Small Intestine.- Colon and Rectum.- Anus.- Gastrointestinal Stromal Tumor.- Neuroendocrine Tumors.- Liver.- Intrahepatic Bile Ducts.- Gallbladder.- Perihilar Bile Ducts.- Distal Bile Duct.- Ampulla of Vater.- Exocrine and Endocrine Pancreas.- Thorax.- Lung.- Pleural Mesothelioma.- Musculoskeletal Sites.- Bone.- Soft Tissue Sarcoma.- Skin.- Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas.- Merkel Cell Carcinoma.- Melanoma of the Skin.- Breast.- Breast.- Gynecologic Sites.- Vulva.- Vagina.- Cervix Uteri.- Corpus Uteri.- Ovary and Primary Peritoneal Carcinoma.- Fallopian Tube.- Gestational Trophoblastic Tumors.- Genitourinary Sites.- Penis.- Prostate.- Testis.- Kidney.- Renal Pelvis and Ureter.- Urinary Bladder.- Urethra.- Adrenal.- Ophthalmic Sites.- Carcinoma of the Eyelid.- Carcinoma of the Conjunctiva.- Malignant Melanoma of the Conjunctiva.- Malignant Melanoma of the Uvea.- Retinoblastoma.- Carcinoma of the Lacrimal Gland.- Sarcoma of the Orbit.- Ocular Adnexal Lymphoma.- Central Nervous System.- Brain and Spinal Cord.- Lymphoid Neoplasms.- Lymphoid Neoplasms.

Read more less

Book SynopsisThis book aims to be a guide to the practice of blood conservation. The first chapter discusses the legal and administrative aspects of bloodless medicine describing the legal principles and practical issues relatd to refusal of transfusion. The second is on balancing the risks and benefits of transfusion includes clinical vignettes of appropriate and inappropriate transfusion. The remainder of the book covers the principles and practice of bloodless medicine, including a chapter on the scientific issues of haemostasis and the investigation of bleeding idsorders. The book concludes with chapters on blood conservation in neonatal and paediatric surgery, the costs associated with blood transfusion and the quest for artifical blood. New chapters will be included to address blood utilization in oncology and geriatric patients.Table of ContentsContributors, ix Preface, xiii 1 History of blood transfusion and patient blood management, 1 Shannon L. Farmer, James Isbister, and Michael F. Leahy 2 The ethical complexities of transfusion-free medicine, surgery and research, 19 Katrina A. Bramstedt 3 Transfusion therapy – Balancing the risks and benefits, 28 Irina Maramica and Ira A. Shulman 4 The physiology of anemia and the threshold for blood transfusion, 61 Senthil G. Krishna, Ahsan Syed, Jason Bryant, and Joseph D. Tobias 5 Blood transfusion in surgery, 83 Sharad Sharma, Lance W Griffin, and Nicolas Jabbour 6 Current view of coagulation system, 102 Yoogoo Kang and Elia Elia 7 Topical hemostatic agents, 143 Fabrizio Di Benedetto and Giuseppe Tarantino 8 Intraoperative strategies for transfusion-free medicine, 158 Joseph D. Tobias 9 Post-operative management in transfusion-free medicine and surgery in the ICU, 207 Jean-Louis Vincent 10 The changing transfusion practice of neonatal and pediatric surgery, 222 Pamela J. Kling and Nicolas Jabbour 11 Current management of anemia in oncology, 247 Shelly Sharma and Sharad Sharma 12 Artificial blood, 271 Aryeh Shander, Mazyar Javidroozi, and Seth Perelman 13 Translational strategies to minimize transfusion requirement in liver surgery and transplantation: Targeting ischemia-reperfusion injury, 289 Reza F. Saidi and S. Kamran Hejazi Kenari 14 Legal and administrative issues related to transfusion-free medicine and surgery programs, 315 Randy Henderson and Nicolas Jabbour 15 Basic principles of bloodless medicine and surgery, 338 Nicolas Jabbour Index, 347

Read more less